help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on July 15, 2004
Endocrinology, doi:10.1210/en.2004-0569
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
145/11/4997    most recent
Author Manuscript (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by DE VRIESE, C.
Right arrow Articles by DELPORTE, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by DE VRIESE, C.
Right arrow Articles by DELPORTE, C.

Submitted on May 5, 2004
Accepted on July 8, 2004

Ghrelin degradation by serum and tissue homogenates: identification of the cleavage sites

CARINE DE VRIESE, FRANCOISE GREGOIRE, ROGER LEMA-KISOKA, MAGALI WAELBROECK, PATRICK ROBBERECHT, and CHRISTINE DELPORTE*

Department of Biochemistry and Nutrition and L. Deloyers Laboratory for Experimental Surgery, Faculty of Medicine, Université Libre de Bruxelles, Brussels, Belgium

* To whom correspondence should be addressed. E-mail: cdelport{at}ulb.ac.be.

The endogenous ligand for the growth hormone secretagogue receptor is ghrelin, a peptide recently purified from the stomach. Ghrelin is n-octanoylated on the Ser3 residue and this modification is essential for its interaction with the receptor. The degradation of ghrelin by rat and human serum, purified commercial enzymes and tissues homogenates was analyzed by combining HPLC and mass spectrometry. In serum, ghrelin was desoctanoylated, without proteolysis. The desoctanoylation was significantly reduced by phenylmethylsulfonyl fluoride (PMSF), a serine proteases and esterases inhibitor. In rat serum, the carboxylesterase inhibitor bis-p-nitrophenyl-phosphate (BNPP) totally inhibited ghrelin desoctanoylation and a correlation was found between ghrelin desoctanoylation and carboxylesterase activity. Moreover, purified carboxylesterase degraded ghrelin. Thus, carboxylesterase could be responsible for ghrelin desoctanoylation in that species. In human serum, ghrelin desoctanoylation was partially inhibited by eserine salicylate and sodium fluoride, two butyrylcholinesterase inhibitors, but not by BNPP and ethylenediamine tetraacetic acid (EDTA). Purified butyrylcholinesterase was able to degrade ghrelin, and there was a correlation between the butyrylcholinesterase and ghrelin desoctanoylation activities in human sera. This suggested that several esterases, including butyrylcholinesterase, contributed to ghrelin desoctanoylation in human serum. In contact with tissues homogenates, ghrelin was degraded by both desoctanoylation and N terminal proteolysis. We identified five cleavage sites in ghrelin between residues -Ser2-(acyl)Ser3- (stomach and liver), -(acyl?)Ser3-Phe4- (stomach, liver and kidney), -Phe4-Leu5- (stomach and kidney), -Leu5-Ser6- and -Pro7-Glu8- (kidney). In all cases, the resulting fragments were biologically inactive.


Key words: ghrelin • degradation • carboxylesterases • butyrylcholinesterase




This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
E. Tham, J. Liu, S. Innis, D. Thompson, B. D. Gaylinn, R. Bogarin, A. Haim, M. O. Thorner, and J.-P. Chanoine
Acylated ghrelin concentrations are markedly decreased during pregnancy in mothers with and without gestational diabetes: relationship with cholinesterase
Am J Physiol Endocrinol Metab, May 1, 2009; 296(5): E1093 - E1100.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Gjedde, E. T. Vestergaard, L. C. Gormsen, A. L. D. Riis, J. Rungby, N. Moller, J. Weeke, and J. O. L. Jorgensen
Serum Ghrelin Levels Are Increased in Hypothyroid Patients and Become Normalized by L-Thyroxine Treatment
J. Clin. Endocrinol. Metab., June 1, 2008; 93(6): 2277 - 2280.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. Liu, C. E. Prudom, R. Nass, S. S. Pezzoli, M. C. Oliveri, M. L. Johnson, P. Veldhuis, D. A. Gordon, A. D. Howard, D. R. Witcher, et al.
Novel Ghrelin Assays Provide Evidence for Independent Regulation of Ghrelin Acylation and Secretion in Healthy Young Men
J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 1980 - 1987.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. Gauna, P. Uitterlinden, P. Kramer, R. M. Kiewiet, J. A. M. J. L. Janssen, P. J. D. Delhanty, M. O. van Aken, E. Ghigo, L. J. Hofland, A. P. N. Themmen, et al.
Intravenous Glucose Administration in Fasting Rats Has Differential Effects on Acylated and Unacylated Ghrelin in the Portal and Systemic Circulation: A Comparison between Portal and Peripheral Concentrations in Anesthetized Rats
Endocrinology, November 1, 2007; 148(11): 5278 - 5287.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
P. J. D. Delhanty, P. M. van Koetsveld, C. Gauna, B. van de Zande, G. Vitale, L. J. Hofland, and A. J. van der Lely
Ghrelin and its unacylated isoform stimulate the growth of adrenocortical tumor cells via an anti-apoptotic pathway
Am J Physiol Endocrinol Metab, July 1, 2007; 293(1): E302 - E309.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. De Vriese, M. Hacquebard, F. Gregoire, Y. Carpentier, and C. Delporte
Ghrelin Interacts with Human Plasma Lipoproteins
Endocrinology, May 1, 2007; 148(5): 2355 - 2362.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
M. Rauh, M. Groschl, and W. Rascher
Simultaneous Quantification of Ghrelin and Desacyl-Ghrelin by Liquid Chromatography-Tandem Mass Spectrometry in Plasma, Serum, and Cell Supernatants
Clin. Chem., May 1, 2007; 53(5): 902 - 910.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
B. P. Hauffa, K. Haase, I. M. Range, N. Unger, K. Mann, and S. Petersenn
The Effect of Growth Hormone on the Response of Total and Acylated Ghrelin to a Standardized Oral Glucose Load and Insulin Resistance in Children with Prader-Willi Syndrome
J. Clin. Endocrinol. Metab., March 1, 2007; 92(3): 834 - 840.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
W. H. Park, Y. J. Oh, G. Y. Kim, S. E. Kim, K.-H. Paik, S. J. Han, A. H. Kim, S. H. Chu, E. K. Kwon, S. W. Kim, et al.
Obestatin Is Not Elevated or Correlated with Insulin in Children with Prader-Willi Syndrome
J. Clin. Endocrinol. Metab., January 1, 2007; 92(1): 229 - 234.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
Y. Nishi, H. Hiejima, H. Mifune, T. Sato, K. Kangawa, and M. Kojima
Developmental Changes in the Pattern of Ghrelin's Acyl Modification and the Levels of Acyl-Modified Ghrelins in Murine Stomach
Endocrinology, June 1, 2005; 146(6): 2709 - 2715.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. De Vriese, F. Gregoire, P. De Neef, P. Robberecht, and C. Delporte
Ghrelin Is Produced by the Human Erythroleukemic HEL Cell Line and Involved in an Autocrine Pathway Leading to Cell Proliferation
Endocrinology, March 1, 2005; 146(3): 1514 - 1522.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2004 by The Endocrine Society